This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
329 * | Tue, 8/3/2010, 10:30 AM - 12:20 PM | CC-302/303 (West) |
The Design and Analysis of Crossover Trials: Some Recent Developments — Topic Contributed Papers | ||
Biopharmaceutical Section | ||
Organizer(s): Byron Jones, Pfizer Inc. | ||
Chair(s): Robb Muirhead, Statistical Scientist | ||
10:35 AM | Sample Size Re-estimation in Crossover Trials — Adina Soaita, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Jerry J. Weaver, Pfizer Inc. | |
10:55 AM | Scaled Average Bioequivalence for Highly Variable Drugs — Scott Patterson, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Dieter Hauschke, University Medical Center Freiburg | |
11:15 AM | Comparing Adaptive and Traditional Crossover Designs for Dose-Finding Trials — James A. Bolognese, Cytel Inc. ; Nitin R. Patel, Cytel Inc. ; Byron Jones, Pfizer Inc. | |
11:35 AM | The Use of Baseline Covariates in Cross-Over Studies — Byron Jones, Pfizer Inc. ; Michael G. Kenward, London School of Hygiene and Tropical Medicine ; James Henry Roger, GlaxoSmithKline | |
11:55 AM | Optimal Crossover Designs for PK Studies — Sergei Leonov, GlaxoSmithKline ; Valerii Fedorov, GlaxoSmithKline ; Byron Jones, Pfizer Inc. | |
12:15 PM | Floor Discussion |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.